Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Pharm Bull ; 42(3): 481-488, 2019.
Article in English | MEDLINE | ID: mdl-30828079

ABSTRACT

Lysine-specific demethylase 1 (LSD1/KDM1A) is a histone demethylase and specifically catalyzes the demethylation of mono- and di-methylated histone H3 lysine 4 (H3K4). The LSD1-mediated demethylation of H3K4 promotes the assembly of the c-Myc-induced transcription initiation complex. Although LSD1 and c-Myc are both strongly expressed in human cancers, the mechanisms by which their activities are coordinated remain unclear. We herein demonstrated that LSD1 is a direct target gene of c-Myc. The knockdown of c-Myc decreased the expression of LSD1 in several cancer cell lines. We identified two non-canonical E-boxes in the proximal promoter region of the LSD1 gene. A chromatin immunoprecipitation assay showed that c-Myc bound to these E-boxes in the LSD1 promoter. Importantly, LSD1 mRNA expression correlated with c-Myc expression in human acute myeloid leukemia (AML), glioblastoma, stomach adenocarcinoma, and prostate adenocarcinoma. The present results suggest that LSD1 is induced by c-Myc and forms a positive feedback mechanism in transcription reactions by c-Myc.


Subject(s)
Histone Demethylases/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Cell Line, Tumor , Databases, Factual , Histone Demethylases/genetics , Humans , Neoplastic Stem Cells , Proto-Oncogene Proteins c-myc/genetics , RNA Interference
2.
Free Radic Res ; 51(7-8): 684-692, 2017.
Article in English | MEDLINE | ID: mdl-28750563

ABSTRACT

High-dose ascorbic acid (AsA) treatment, known as pharmacological AsA, has been shown to exert carcinostatic effects in many types of cancer cells and in vivo tumour models. Although pharmacological AsA has potential as a complementary and alternative medicine for anticancer treatment, its effects on human tongue carcinoma have not yet been elucidated. In this study, we investigated the effect of AsA treatment on human tongue carcinoma HSC-4 cells compared with non-tumourigenic tongue epithelial dysplastic oral keratinocyte (DOK) cells. Our results show that treatment with 1 and 3 mM of AsA for 60 min preferentially inhibits the growth of human tongue carcinoma HSC-4 over DOK cells. Furthermore, AsA-induced effects were accompanied by increased intracellular oxidative stress and were repressed by treatment with a hydrogen peroxide (H2O2) scavenger catalase and a superoxide anion radical (O2-) scavenger, tempol. Time-lapse observation and thymidine analog EdU incorporation revealed that AsA treatment induces not only cell death but also suppression of DNA synthesis and cell growth. Moreover, the growth arrest was accompanied by abnormal cellular morphologies whereby cells extended dendrite-like pseudopodia. Taken together, our results demonstrate that AsA treatment can induce carcinostatic effects through induction of cell death, growth arrest, and morphological changes mediated by H2O2 and O2- generation. These findings suggest that high-dose AsA treatment represents an effective treatment for tongue cancer as well as for other types of cancer cells.


Subject(s)
Ascorbic Acid/administration & dosage , Carcinoma/drug therapy , Free Radical Scavengers/metabolism , Tongue Neoplasms/drug therapy , Apoptosis/drug effects , Ascorbic Acid/adverse effects , Carcinoma/metabolism , Carcinoma/pathology , Catalase/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Humans , Hydrogen Peroxide/toxicity , Oxidation-Reduction , Oxidative Stress/drug effects , Superoxide Dismutase/metabolism , Superoxides/toxicity , Tongue Neoplasms/metabolism , Tongue Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...